Skip to main content
Berry Genomics Co.,Ltd logo

Berry Genomics Co.,Ltd — Investor Relations & Filings

Ticker · 000710 ISIN · CNE000000PN7 Shenzhen Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 2,009 across all filing types
Latest filing 2022-09-19 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 000710

About Berry Genomics Co.,Ltd

https://www.berrygenomics.com

Berry Genomics Co.,Ltd. is a biotechnology enterprise specializing in clinical genomics and genetic testing services. The company focuses on the research, development, and commercialization of genomic technologies for clinical applications. Its core portfolio includes non-invasive prenatal testing (NIPT), utilizing high-throughput sequencing to screen for chromosomal abnormalities. Beyond reproductive health, the company provides genomic solutions for oncology diagnostics, including early cancer screening and companion diagnostics, as well as testing for hereditary diseases. Berry Genomics leverages advanced sequencing platforms and proprietary bioinformatics pipelines to deliver precision medicine tools to healthcare providers and research institutions. The company is recognized for its role in the clinical application of Next-Generation Sequencing (NGS) and its extensive genomic databases used to enhance diagnostic accuracy and therapeutic outcomes.

Recent filings

Filing Released Lang Actions
独立董事关于补选公司独立董事的独立意见
Board/Management Information Classification · 95% confidence The document is an independent opinion from independent directors regarding the election of a new independent director for the company. It references compliance with company law and stock exchange listing rules, and discusses the nomination and qualifications of the candidate. There is no financial data, no report publication, no voting results, and no mention of a general meeting or shareholder vote results. This is a board/management related announcement about changes in the board composition, specifically the nomination of an independent director. Therefore, it fits best under Board/Management Information (MANG). The document length is short and focused on management nomination, not a full report or announcement of voting results.
2022-09-19 Chinese
独立董事提名人声明
Board/Management Information Classification · 95% confidence The document is a formal statement from the board nominating an independent director candidate for the company's board. It includes detailed declarations about the nominee's qualifications, compliance with regulatory requirements, and independence criteria. There is no financial data, no mention of financial results, no discussion of management changes beyond the nomination, and no reference to shareholder voting results or meeting materials. The document is a nomination statement related to board composition but does not announce an actual change or election result. This type of document fits best under Board/Management Information (MANG), as it concerns board member nomination and related disclosures.
2022-09-19 Chinese
第九届董事会第二十次会议决议公告
Board/Management Information Classification · 100% confidence The document is a formal announcement of the resolutions passed at the 20th meeting of the 9th Board of Directors of the company. It includes details about the meeting date, attendance, voting results on various proposals such as guarantees for subsidiaries, election of an independent director, and scheduling of an extraordinary general meeting. The document also includes a biography of the newly nominated independent director. There are no financial statements or detailed financial data presented. The content focuses on board decisions and management changes, specifically the appointment of a new independent director. Therefore, this document fits the category of Board/Management Information (MANG). The document length is short (1828 characters), and it is not an announcement of a report publication but a substantive announcement of board decisions.
2022-09-19 Chinese
关于控股股东及其一致行动人进行股票质押式回购交易补充质押的公告
Major Shareholding Notification Classification · 95% confidence The document is an announcement regarding the supplementary pledge of shares by the controlling shareholder and its concerted parties. It details the number of shares pledged, the proportion of shares pledged relative to total holdings and company capital, and risk warnings related to the high pledge ratio. There is no financial statement, earnings data, or management discussion. The document is a regulatory announcement about share pledge transactions by major shareholders, which fits the category of Major Shareholding Notification (MRQ). The document length is short (2084 characters), and it is not a report or a certification but a disclosure of share pledge details by controlling shareholders.
2022-09-19 Chinese
独立董事候选人声明
Board/Management Information Classification · 95% confidence The document is a formal declaration by an independent director candidate of Chengdu Berry Genomics Co., Ltd. It contains detailed statements about the candidate's qualifications, compliance with laws and regulations, and independence criteria. There is no financial data, no discussion of company performance, no voting results, no management changes, and no mention of any report publication. The content is focused on the candidate's eligibility and compliance with regulatory requirements for serving as an independent director. This type of document is related to board or management information, specifically announcements or declarations about board members or candidates. Therefore, the most appropriate classification is Board/Management Information (MANG). The document length is sufficient and the content is substantive, not a mere announcement or certification, so it is not Regulatory Filings (RNS).
2022-09-19 Chinese
关于为全资子公司提供担保的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the provision of guarantees by the parent company for its wholly-owned subsidiaries' bank credit facilities. It includes details about the guarantee amounts, terms, and the subsidiaries' financial data. The document references board resolutions approving the guarantees and compliance with regulatory requirements. It does not contain a full financial report or detailed financial statements but rather a specific corporate action related to financing and guarantees. The document length is 3141 characters, which is relatively short and focused on a specific financing-related announcement. Therefore, it fits best under the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes, including guarantees for subsidiaries' borrowings.
2022-09-19 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.